Author: Acumen Research and Consulting

Digital PCR and Real-time PCR Market, valued at USD 7.8 Billion in 2022, is projected to exceed USD 18.6 Billion by 2032, anticipating a 9.2% CAGR

The digital PCR (dPCR) and real-time PCR (qPCR) industries were booming, thanks to advances in molecular biology methods and rising demand for accurate and sensitive nucleic acid measurement. Digital PCR, a method that permits absolute quantification of DNA or RNA molecules without the need of a standard curve, was gaining popularity for applications such as rare allele discovery, copy number variation analysis, and nucleic acid absolute quantification. Real-time PCR, on the other hand, has remained a popular technology due to its speed and sensitivity in monitoring DNA amplification during the PCR process. With continued improvements in automation and high-throughput capabilities, both sectors benefited from expanded applications in research, clinical diagnostics, and biotechnology.

Market trends suggested that an increasing emphasis on personalized medicine, genetics, and diagnostics was pushing the use of both digital PCR and real-time PCR technologies. Furthermore, the COVID-19 pandemic highlighted the need of PCR technology in diagnostic testing.

Digital PCR and Real-time PCR Market Statistics

• Global digital PCR and real-time PCR market revenue reached USD 7.8 billion in 2022
• Anticipated digital PCR and real-time PCR market CAGR is predicted at 9.2% from 2023 to 2032
• North America led the digital PCR and real-time PCR market with over a 36% share in 2022
• Asia-Pacific is expected to achieve a CAGR exceeding 9.2% from 2023 to 2032
• Insulin delivery devices dominated the application segment with a 61% market share in 2022
• Clinical application claimed over USD 4.06 billion in revenue in 2022
• A notable digital PCR and real-time PCR market trend is the increasing integration of these technologies with next-generation sequencing (NGS) platforms

Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/1392

Digital PCR and Real-time PCR Market Dynamics

Increasing Demand for High-Throughput Screening In Research and Diagnostics Fuels the Digital PCR and Real-time PCR Market Value

The rising need for high-throughput screening (HTS) in both research and diagnostics has boosted the market value of digital PCR and real-time PCR technologies. High-throughput screening includes the quick and automated examination of a large number of samples, making it especially useful for drug development, genetic testing, and disease monitoring.

Digital PCR and real-time PCR technologies are well-suited for high-throughput applications because to their speed, sensitivity, and accuracy. Researchers and diagnostic laboratories are increasingly depending on PCR technologies to rapidly handle huge numbers of samples, allowing for speedy and cost-effective screening of genetic material. The capacity to evaluate several samples at the same time not only speeds up research efforts but also improves the scalability of diagnostic operations, especially in the context of genetic illnesses.

As the need for speedy and thorough screening solutions grows in both research and clinical settings, digital PCR and real-time PCR for high-throughput applications are projected to contribute considerably to overall market development in the near future.

Growing Demand for Point-Of-Care Testing and Diagnostics Offers Significant Digital PCR and Real-time PCR Market Opportunity

The increased need for point-of-care (POC) testing and diagnostics has generated a sizable market potential for digital PCR and real-time PCR technologies. POC testing entails performing diagnostic tests on or near the patient, allowing for quick findings and decision-making. Both digital PCR and real-time PCR technologies are well-suited for point-of-care applications, leading to their rising use in decentralized healthcare settings.

Digital PCR and real-time PCR yield precise and consistent findings, making them important tools for detecting infectious illnesses, monitoring chronic disorders, and doing quick genetic testing at the point of care. The trend toward personalized medicine and the emphasis on early illness identification increase the need for point-of-care testing technologies even further, with digital PCR and real-time PCR playing critical roles in delivering accurate and fast information for clinical decision-making.

The market for digital PCR and real-time PCR is likely to profit greatly from the rising prospects in the POC testing category as the healthcare industry continues to emphasize accessible and efficient diagnostic solutions. This tendency reflects a larger move toward decentralized healthcare delivery methods, as well as the growing relevance of molecular diagnostics in enabling speedy and tailored patient treatment.

Digital PCR and Real-time PCR Market Segmentation

The global market for digital PCR and real-time PCR has been segmented into technology, product, application, and region.

• The technology segment is bifurcated into digital PCR and quantitative PCR
• Instruments, reagents and consumables, and software & services are the products considered in the market
• The application segment is split into research, forensic, clinical (pathogen testing, oncology testing, blood screening, and others)
• The geographical segmentation of the digital PCR and real-time PCR market encompasses Asia-Pacific, Latin America, North America, Europe, and the Middle East and Africa (MEA)

Digital PCR and Real-time PCR Market Regional Outlook

The North American area, notably the United States, has played a significant role in the expansion of the digital PCR and real-time PCR markets. The existence of important market participants, a strong research infrastructure, and a strong emphasis on modern healthcare technology have all contributed to widespread acceptance. Market growth has been supported by applications in genomics research, clinical diagnostics, and pharmaceutical development.

Digital PCR and real-time PCR technology have also seen widespread use in European countries. Precision medicine, research partnerships, and the availability of a sophisticated healthcare system have all contributed to market expansion in the area. Significant themes include increased use in infectious disease diagnostics and customized treatment.

The Asia-Pacific area is seeing a surge in demand for these technologies as a result of expanded research activities, developing biotechnology industries, and a growing emphasis on genomics. China, Japan, and India are major contributors to the regional market. Initiatives in genomes research, cancer investigations, and infectious disease management are frequently driving uptake.

Digital PCR and Real-time PCR Market Players

Digital PCR and real-time PCR companies profiled in the report include Abbott Laboratories, Agilent Technologies, Inc., Becton and Dickinson Company, Bio Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann La Roche Ltd., Fluidigm Corporation, Merck KGaA, Qiagen N.V., Takara Bio, Inc, and Thermo Fisher Scientific, Inc.

Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/1392

Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/1392

Mr. Frank Wilson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: sales@acumenresearchandconsulting.com